You have 9 free searches left this month | for more free features.

Aflibercept

Showing 26 - 50 of 521

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Learn More About How Drug Aflibercept Works in Canadian Reduced

Active, not recruiting
  • Myopic Choroidal Neovascularization
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Canada
    Many Locations
Jul 25, 2022

Neovascular Glaucoma Trial in Aurora (Aflibercept)

Completed
  • Neovascular Glaucoma
  • Aflibercept
  • Aurora, Colorado
    Rocky Mountain Lions Eye Institute
Feb 16, 2022

Wet Age-related Macular Degeneration Trial in Bern (Aflibercept, Brolucizumab, early treat and extend (T&E))

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Aflibercept
  • +2 more
  • Bern, Switzerland
    Berner Augenklinik am Lindenhofspital
May 13, 2022

Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration
  • Aflibercept(BAY86-5321, Eylea)
  • (no location specified)
Jul 22, 2022

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • +2 more
  • Intravitreal aflibercept injection
  • Seoul, Korea, Republic of
    Jae Hui Kim
Dec 20, 2022

Aflibercept Injection in Japanese Neovascular Glaucoma (NVG)

Recruiting
  • Neovascular Glaucoma
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Japan
    Many locations
Aug 17, 2022

Diabetic Macular Edema Trial in Palo Alto (Intravitreal Aflibercept)

Withdrawn
  • Diabetic Macular Edema
  • Intravitreal Aflibercept
  • Palo Alto, California
    Byers Eye Institute
Apr 21, 2022

Diabetic Macular Edema With Intravitreal Aflibercept Injection

Active, not recruiting
  • Diabetic Macular Edema
  • Aflibercept Injection [Eylea]
  • South Dartmouth, Massachusetts
    Advanced Eye Centers
Feb 17, 2022

Use of Aflibercept Injections Into Eye for Treatment of Eye

Recruiting
  • Retinal Disease
  • Aflibercept (BAY86-5321, Eylea)
  • Multiple Locations, Mexico
    Many locations
Aug 22, 2022

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,

Recruiting
  • Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
  • intravitreal injection of Ranibizumab
  • +3 more
  • Qinā, Qena, Egypt
    Ahmed Ali Ahmed Amer
Mar 15, 2022

Intravitreal Aflibercept in Diabetic Macular Edema and/or

Completed
  • Macular Edema
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, China
  • +10 more
Nov 10, 2022

Retinal Detachment With Multiple Breaks, Unspecified Eye, Proliferative Vitreoretinopathy Trial in Philadelphia (Intravitreal

Recruiting
  • Retinal Detachment With Multiple Breaks, Unspecified Eye
  • Proliferative Vitreoretinopathy
  • Intravitreal aflibercept injection
  • Sham control
  • Philadelphia, Pennsylvania
    Wills Eye Hospital
May 2, 2022

Neovascular Age-Related Macular Degeneration Trial in Worldwide (Ranibizumab, Aflibercept, Port Delivery System with ranibizumab

Suspended
  • Neovascular Age-Related Macular Degeneration
  • Capital Federal, Argentina
  • +9 more
Nov 8, 2022

Maximum Treatment Interval With Aflibercept T&E

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept Injection [Eylea]
  • Taipei, Taiwan
    Shin Kong Memorial Wu Ho-Su Hospital
Apr 19, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Exudative Age-related Macular Degeneration Trial (intravitreal injection)

Completed
  • Exudative Age-related Macular Degeneration
  • intravitreal injection
  • (no location specified)
Apr 19, 2022

Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

Recruiting
  • Wet Age-related Macular Degeneration
  • Melbourne, Florida
  • +4 more
Aug 18, 2022

Diabetic Retinopathy Trial in Montemorelos (Intravitreal bevacizumab or intravitreal ziv-aflibercept)

Completed
  • Diabetic Retinopathy
  • Intravitreal bevacizumab or intravitreal ziv-aflibercept
  • Montemorelos, Nuevo Leon, Mexico
    Hospital La Carlota
Nov 20, 2021

Aflibercept in Routine Clinical Practice in Diabetic Macular

Completed
  • Macular Edema
  • Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
  • Anti-VEGF therapies including: Eylea Aflibercept, VEGF Trap-Eye, BAY86-5321) and Ophthalmologicals / Antineovascularisation agents (S01LA05)
  • Multiple Locations, United Kingdom
    (unnamed)
Nov 1, 2021

Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Beijing, Beijing, China
    Beijing tongren hospital affliated to capital medical university
Apr 5, 2022

Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

Completed
  • Diabetic Macular Edema
  • Beijing, Beijing, China
    Beijing tongren hospital affliated to capital medical university
Apr 5, 2022

Diabetic Macular Edema Trial in United States (intravitreous aflibercept, Bevacizumab + Deferred Aflibercept Group)

Completed
  • Diabetic Macular Edema
  • intravitreous aflibercept
  • Bevacizumab + Deferred Aflibercept Group
  • Campbell, California
  • +53 more
Nov 28, 2022

Diabetic Macular Edema Trial in China (Brolucizumab, Aflibercept)

Active, not recruiting
  • Diabetic Macular Edema
  • Guangzhou, Guangdong, China
  • +23 more
Jan 20, 2023

Neovascular Age-Related Macular Degeneration Trial in China (Brolucizumab 6mg, Aflibercept 2 mg)

Recruiting
  • Neovascular Age-Related Macular Degeneration
  • Brolucizumab 6mg
  • Aflibercept 2 mg
  • Guangzhou, Guangdong, China
  • +30 more
Jan 20, 2023

Chorioretinal Vascular Disease Trial in Houston, The Woodlands (Intravitreal Aflibercept Injection (IAI))

Completed
  • Chorioretinal Vascular Disease
  • Intravitreal Aflibercept Injection (IAI)
  • Houston, Texas
  • +1 more
Aug 18, 2021